SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

bioAffinity advances CyPath Lung test for lung cancer survivor surveillance

bioAffinity Technologies said it is advancing the potential application of its CyPath Lung test for surveillance of lung cancer survivors.

BIAF

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories